Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.
about
Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature.Autoimmunity in 2016.Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.[Cryoglobulinemic vasculitis].Correlation of CCR5 and NLRP3 gene polymorphisms with renal damage due to hepatitis C virus-related cryoglobulinemia
P2860
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Retreatment regimen of rituxim ...... controlled multicentre study.
@ast
Retreatment regimen of rituxim ...... controlled multicentre study.
@en
type
label
Retreatment regimen of rituxim ...... controlled multicentre study.
@ast
Retreatment regimen of rituxim ...... controlled multicentre study.
@en
prefLabel
Retreatment regimen of rituxim ...... controlled multicentre study.
@ast
Retreatment regimen of rituxim ...... controlled multicentre study.
@en
P2093
P50
P1476
Retreatment regimen of rituxim ...... controlled multicentre study.
@en
P2093
Antonio Tavoni
Armando Gabrielli
Cesare Mazzaro
Clodoveo Ferri
Costanza Sbreglia
Dario Roccatello
Davide Filippini
Francesca Zuliani
Francesco Saccardo
Giuseppe Monti
P356
10.1016/J.JAUT.2015.07.012
P577
2015-08-05T00:00:00Z